Research Explains How Precision Cancer Drug Works and Who May Benefit
New research that uncovers the mechanism behind the newest generation of cancer drugs is opening the door for better-targeted therapy. PARP inhibitors are molecular-targeted cancer drugs used to treat women with ovarian cancer who have the BRCA1 and BRCA2 gene mutations. The drugs are showing promise in late-stage clinical trials for breast cancer, prostate cancer, ...